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ABSTRACT 
The role of immunization in the production of antibodies directed against immunogens is widely appreciated in 
laboratory animals and in humans. However, the role of immunization in the development of “natural antibodies” 
has not been investigated. Natural antibodies are those antibodies present without known history of infection or 
immunization, and react to a wide range of targets, including “cryptic” self-antigens that are exposed upon cell 
death. In this study, the ability of immunization to elicit the production of natural antibodies in laboratory rats was 
evaluated. Laboratory rats were immunized with a series of injections using peanut extracts (a common allergen), 
a high molecular weight protein conjugated to hapten (FITC-KLH), and a carbohydrate conjugated to hapten (DNP-
Ficall). Significantly greater binding of antibodies from immunized animals compared to controls was observed to 
numerous autologous organ extracts (brain, kidney, liver, lung, prostate, and spleen) for both IgM and IgG, alt-
hough the effect was more pronounced for IgM. These studies suggest that immunization may have at least one 
unforeseen benefit, enhancing networks of natural antibodies that may be important in such processes as wound 
repair and tumor surveillance. Such enhancement of natural antibody function may be particularly important in 
Western society, where decreased exposure to the environment may be associated with a weakened natural anti-
body repertoire. 
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INTRODUCTION 
The term ‘natural antibodies’ describes 
immunoglobulin molecules produced against 
antigens without known history of immuniza-
tion or infection (Schwartz-Albiez et al., 
2009). Natural antibodies are important for in-
nate immune defense against potential patho-
gens and in the recognition and removal of ab-
normal cells (Grönwall et al., 2012). It is the 
latter function that likely explains the signifi-
cance of natural antibodies in tumor surveil-
lance and cancer prevention (Umar, 2014). 
Natural antibodies typically bind to the carbo-
hydrate moieties and glycans expressed by 
precancerous and cancerous cells (Vollmers 
and Brandlein, 2009), although natural anti-
bodies also bind to a variety of “neoepitopes” 
that become exposed when autologous cells 
are disrupted (Ailus and Palosuo, 1995; Casali 
and Schettino, 1996; Guilbert et al., 1982; La-
croix-Desmazes et al., 1998; Logtenberg, 
1990; Lydyard et al., 1990; Parker et al., 1997; 
Quan et al., 1997; Spalter et al., 1999; Stahl et 
al., 2000; Vassilev and Veleva, 1996). 
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Current research suggests that the natural 
antibody repertoire is inherently linked to the 
host biome. For example, one of the differ-
ences between wild rodents and laboratory ro-
dents is that the wild animals have much 
higher natural antibody levels compared to 
their laboratory counterparts (Devalapalli et 
al., 2006). Recently Pi et al. (2015) found that 
exposing laboratory rats to ‘wild like’ condi-
tions partially reconstituted the natural anti-
body repertoire. This practice of exposing an 
organism to foreign antigens to manipulate 
immune function closely resembles the com-
monly used medical practice of vaccination, 
also known as immunization. Vaccination, 
one of the keystones of modern medicine, in-
duces the formation of memory B-cells and 
antibodies that confer immunity to disease 
causing pathogens. Modern vaccination 
schedules expose patients to a variety of im-
munogenic compounds. Whilst primarily 
aimed at disease prevention, this exposure 
may have an unintended impact on the natural 
antibody repertoire. 
This study examines the effect of vaccina-
tion on the natural IgM and IgG antibody rep-
ertoire. Sprague Dawley laboratory rats were 
given an immunization protocol designed to 
broadly stimulate the humoral immune sys-
tem. The immunization cocktail included hap-
ten conjugates with protein and carbohydrate 
carriers to provoke T-cell-dependent and -in-
dependent responses, respectively, as well as 
peanut extracts. The binding of natural anti-
bodies from the sera of immunized and non-
immunized rats to antigens extracted from rat 
organs was then quantitatively assessed. 
 
METHODS 
Animals 
Male (n=4) and female (n=8) Sprague 
Dawley rats were purchased from Harlan 
Sprague Dawley (Indianapolis, IN).  The rats 
were acclimatized in standard animal housing 
at Duke University for 62 days. Once accli-
matized, the rats were bred. The 31 female rats 
that resulted from the breeding were utilized 
for the experiments in this study. All animal 
housing and procedures were approved by the 
Duke University Medical Center Institutional 
Animal Care and Use committee. 
 
Experimental design 
In order to evaluate the effect of immun-
ization on the natural antibody repertoire, 20 
of the 31 female rats were immunized with a 
cocktail containing peanut extract, fluorescein 
isothiocyanate labelled keyhole limpet hemo-
cyanin (FITC-KLH) and 2,4-dinitrophenyl 
conjugated to AminoEthylCarboxyMethyl-
FICOLL (DNP-Ficoll, Biosearch Technolo-
gies Inc. Novato, CA USA). The peanut ex-
tract was used to promote an IgE response, 
whilst FITC-KLH and DNP-Ficoll were used 
for T-cell-dependent and T-cell-independent 
stimulation, respectively. The remaining 11 
rats acted as controls and did not receive any 
immunization. All rats were euthanized by 
CO2 inhalation at 71 days of age. Blood was 
collected from the posterior vena cava and 
centrifuged, and sera were stored at -80 °C 
until use. 
 
Production of peanut extract 
The peanut extract was prepared as previ-
ously described by Pi et al. (2015). Raw pea-
nuts were lightly blanched at 100 °C for 3 min 
and pulverized using a BioPulverizer (Bio-
spec Products, Inc. Bartlesville, OK, USA). 
Pulverized peanuts were then mixed with 
phosphate buffered saline (Roche, Indianapo-
lis, IN, USA) at a 1 kg:4 L ratio. A homoge-
nizer (OMNI GLH) was used to further ho-
mogenize the peanut-PBS mixture. The mix-
ture was stirred overnight at 4 °C, then centri-
fuged for 30 minutes at 100 x g at room tem-
perature. The aqueous fraction was centri-
fuged for 30 more minutes at 100 x g at room 
temperature to remove residual lipids. The re-
maining aqueous fraction, or “peanut extract”, 
was collected and stored at -80 °C until use. A 
Pierce BCA Protein Assay Kit (Thermo Sci-
entific, Rockford, IL, USA) was used to de-
termine the protein concentration. The extract 
was stored so that each aliquot was thawed 
only once prior to use. 
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Synthesis of FITC-KLH 
Conjugation and purification of FITC-
KLH was conducted as previously described 
(Pi et al., 2015). To begin with, 1.5 mL of 
10mg/mL KLH (Sigma-Aldrich, St. Louis, 
MO, USA) was dialyzed against 2 L of 
100 mM NaCO3 buffer at pH 9.3, in dialysis 
tubing (MWCO: 3,500; VWR Scientific, Ran-
cho Dominguez, CA, USA). The mixture was 
kept at 4 °C for 24 hours and the dialysis so-
lution was changed once during this process. 
FITC (Sigma-Aldrich, St. Louis, MO, USA) 
and KLH were then combined at a 20 µg:1 mg 
ratio, and incubated for 1.5 hours at room tem-
perature. Next, the FITC-KLH conjugate was 
dialyzed in 500 mL saline solution overnight 
at 4 °C. The buffer was changed, and the sam-
ple was dialyzed for 2 hrs at room tempera-
ture. The absorbance of purified FITC-KLH 
was read at 280 nm and 495 nm, and the la-
beling ratio (FITC:Protein) was determined 
based on the ratio of those absorbancies. Two 
batches, with labeling ratios 2.4 and 5.3, were 
made and pooled. Labeled FITC-KLH was 
stored at -80 °C, in a manner that ensured each 
aliquot was only thawed once before use. 
 
Immunization cocktail 
An immunization cocktail was mixed to 
provide broad antigenic stimulation with a 
single injection. Previously frozen aliquots of 
peanut extract, FITC-KLH and DNP-Ficoll 
were thawed and mixed in PBS, to concentra-
tions of 2 mg/ml, 1 mg/ml and 2 mg/ml re-
spectively. The resulting mixture was ali-
quoted and frozen to -80 °C until use. 
 
Immunization protocol 
The immunization protocol consisted of 6 
intraperitoneal injections over 14 days and is 
summarized in Table 1. Rats were weighed 
and given the first injection at 43 days of age, 
designated day 0. This injection contained 
1 mL/kg of the immunization cocktail and 
1 mL/kg of Inject Alum (Pierce, Rockford, IL, 
USA) mixed for 30 minutes at room tempera-
ture on an Everlast rocker. Using the day 0 
weight as the basis, the rats were given a 
2 mg/kg body weight intraperitoneal injection 
of peanut extract on days 2, 4, 7 and 9. The 
immunization protocol concluded on day 14 
with a final injection of 1 ml/kg of the immun-
ization cocktail, without the Inject Alum. The 
resulting immunization schedule is detailed in 
Table 1. All rats were euthanized 28 days after 
the first injection, at 71 days old. 
 
Table 1: Dosing and schedule of immunization 
protocol 
Day 
(age) 
Injected Dose 
0 (43) Immunization cocktail 
Peanut extract 
FITC-KLH 
DNP-Ficoll 
Alum 
1 ml/kg 
2 mg/kg 
1 mg/kg 
2 mg/kg 
1 ml/kg 
2 (45) Peanut extract 2 mg/kg 
4 (47) Peanut extract 2 mg/kg 
7 (50) Peanut extract 2 mg/kg 
9 (52) Peanut extract 2 mg/kg 
14 (57) Immunization cocktail 
Peanut extract 
FITC-KLH 
DNP-Ficoll 
1 ml/kg 
2 mg/kg 
1 mg/kg 
2 mg/kg 
28 (71) All rats euthanized 
 
 
 
Preparation of tissue extracts 
Tissue extracts were prepared by a method 
similar to that previously described (Pi et al., 
2015). These extracts provide autologous an-
tigens for recognition by natural antibodies 
from the rat serum. For this purpose, 1 brain, 
4 kidneys, 1 liver, 2 right lungs, 9 prostates 
and 7 spleens were collected from male WKY 
rats. The livers were washed with normal sa-
line solution to remove excess blood. Per-
fadex solution (XVIVO Perfusion AB, Gote-
borg, Sweden) was used to perfuse the lungs 
via the pulmonary arteries. Other organs were 
not perfused. Once collected, individual or-
gans were flash frozen with liquid nitrogen. 
All organs of the same type were pooled to-
gether and a Biopulverizer (Biospec products, 
Bartlesville, OK) was used to form a tissue 
powder. Tissue powders were then thawed to 
4 °C and washed. The washing process began 
with the suspension of the tissue powder in 
4.35 mL/g of PBS followed by mechanical ag-
itation. This was followed by 1 minute in the 
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centrifuge at 90 g, after which the liquid su-
pernatant was removed. The brain, liver, lung 
and prostate powders were all washed twice. 
Due to the high blood content, the kidney 
powder was washed 4 times and the spleen 
powder was washed 5 times. After the final 
wash, PBS was used to adjust the concentra-
tion of each suspension to 0.18 gram of tissue 
powder/mL. The suspensions were then ho-
mogenized with two 45 second pulses in an 
OmnI GLH homogenizer (NW Kennesaw, 
GA). This process lysed cell membranes to 
expose sequestered intracellular antigens. The 
homogenized solutions were then spun at 
9,170 g for 30 minutes at 4 °C. Finally, the 
liquid supernatant was collected, mixed with 
10 % glycerol and stored at -80 °C. The entire 
process yielded 6 organ extracts with protein 
concentrations listed in Table 2. Brain, kidney 
and liver extracts were diluted with PBS at 
1:1.3, 1:2 and 1:3 ratios, respectively, prior to 
use. 
 
 
Table 2: Total protein concentrations of organ 
extracts 
Organ Neat Concentration (mg/ml) 
Brain 7.19* 
Kidney 12.95* 
Liver 18.67* 
Lung 5.95 
Prostate 5.60 
Spleen 5.50 
Determinations were made using a DC Protein Assay Kit 
with the microplate assay protocol (Bio-rad Laboratories, 
Hercules CA). *Brain, kidney, and liver extracts were diluted 
in PBS to respective concentrations of 5.53, 6.48, and 6.22 
mg/mL, respectively, before use in immunoblotting. 
 
 
Preparation of PVDF membranes for  
immunoblot 
Once collected, washed and homoge-
nized, organ extracts were loaded onto PVDF 
membranes for immunoblotting. For this pur-
pose, 280 µL of each organ extract (brain, kid-
ney and liver, prepared and diluted as de-
scribed above) was mixed with 108 µL SDS 
sample buffer (4x) (Novex NuPAGE®, Life 
Technologies), and 43 µL sample reducing 
agent (10x) (Novex NuPAGE®). Each mix-
ture was vortexed, boiled for 7 minutes at 
100 °C, vortexed again and centrifuged for 7 
minutes at 15,996 x g. Subsequently, a 200 µL 
volume of each antigen mixture was loaded 
into the large well of each of two 4-12 % 
acrylamide gradient preparation gels (Novex 
NuPAGE® 4-12 % Bis-Tris ZOOMTM Gel). 
The standard wells of each gel were loaded 
with 5 µL of a molecular weight standard 
(PageRuler Plus). Once loaded, protein elec-
trophoresis with SDS PAGE was used to sep-
arate the antigen mixture. Brain and liver ex-
tracts were run at 45 V for 4 hr 50 min; kidney 
extract was run at 55 V for 4 hr; lung and 
prostate extracts were run at 65 V for 3 hr 15 
min, and spleen extract was run at 70 V for 
3 hr. 
Once separated, antigens were transferred 
to PVDF membranes for 7 minutes at 20 V us-
ing an iBlotTM gel transfer device (Ethrog Bi-
otechnologies Ltd., Invitrogen). PVDF mem-
branes were blocked for 70 minutes at room 
temperature using 1.0   bovine serum albu-
min, 0.1 % Tween 20, and 1x sodium azide in 
Tris buffered saline (blocking buffer). Each 
membrane was then cut into 16 strips (exclud-
ing the standard strip), each 4 mm wide. 
 
Immunoblotting 
Sera were randomly selected from 8 of the 
20 immunized rats and 8 of the 11 non-im-
munized rats. Membrane strips were incu-
bated overnight at 4 °C with specific rat sera 
diluted 1/400 in blocking buffer. A control 
strip was incubated overnight in blocking 
buffer to account for anti-IgG and anti-IgM 
conjugate binding directly to organ-derived 
antigens. The next morning, the strips were 
washed 3 times for 10 minutes each with Tris 
buffered saline. Strips were then incubated for 
1 hour at room temperature in alkaline-phos-
phatase conjugated, affinity purified goat an-
tibody diluted at 1/1000 in blocking buffer. 
Goat antibody specific for the Fc region of rat 
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IgG (Sigma-Aldrich) was used to detect natu-
ral IgG binding. Meanwhile, goat antibody 
specific for rat µ-chain (Sigma-Alrich) was 
used to detect natural IgM binding. After 1 
hour, strips were washed another 3 times for 
10 minutes each in Tris buffered saline. Once 
washed, 1-StepTM NBT-BCIP (nitro blue te-
trazolium and 5-bromo-4-chloro-3-indolyl-
phosphate; Thermo Scientific) was used to de-
velop the strips. Strips incubated in goat anti-
rat IgG were developed for 28 minutes with 
fresh developer added after 14 minutes. Alter-
natively, strips incubated with goat anti-rat 
IgM were developed for 7 minutes. To con-
clude the process, all strips were washed with 
distilled water twice for 6 minutes each and 
air dried. 
 
Immunoblot analysis 
Dried blots were scanned and Quantity 
One software v. 4.6.6 (Bio-Rad Laboratories) 
was utilized to quantify the substrate develop-
ment on each image, corresponding to the 
amount of natural antibody binding to anti-
gens. For each blot, the image intensity was 
manually adjusted to eliminate background 
noise, and the sensitivity was manually con-
figured to maximize the congruency between 
the computer detected bands and the bands de-
tectable to the investigator upon visual inspec-
tion. Similarly, the noise filter was adjusted to 
account for artifacts, typically small, that did 
not correspond to protein bands on the gel. 
Natural antibody binding was quantified 
by several measures. The size of a single band 
was calculated by plotting a curve of the aver-
age intensity of all pixels in each row of the 
band against the band length. The area under 
this curve was taken as the size (Intensity x 
mm) of that band. Once all bands were identi-
fied, the size of the bands on the control strip 
was subtracted from the corresponding bands 
on all other strips. If the band size on the con-
trol strip was greater than the band size on an 
experimental strip, then this band was ex-
cluded from all analysis. The average band 
size associated with the serum of a given ani-
mal was defined as the average of all band 
sizes in a single strip, and the average band 
size for the group was calculated using the 
mean band size of all the blots in that group. 
The number of bands detected was taken as a 
measure of the number of antigens recognized 
by the natural antibody repertoire. Subse-
quently, the total natural antibody binding for 
a particular organ extract was taken as the sum 
intensity of all bands. Both total binding and 
band size were measured in arbitrary units of 
intensity that depend on developing time and 
exposure among other factors such as the na-
ture of the enzyme conjugate. With that in 
mind, both measures were normalised to the 
mean of the non-immunized group. All calcu-
lations were performed for IgM and IgG anti-
body isotypes. 
 
Statistical analysis 
The natural antibody binding characteris-
tics of the sera from non-immunized and im-
munized rats were compared with unpaired, 
two tailed t-tests. All calculations were per-
formed with Graphpad Prism Software 
(Graphpad Software, La Jolla CA). 
 
RESULTS 
Average number of antigens recognized by 
natural antibodies from non-immunized 
and immunized rats 
A typical blot pattern using sera from im-
munized and unimmunized animals is shown 
in Figure 1. The number of antigens recog-
nized by natural antibodies was determined by 
immunoblotting and Bio-Rad Quantity One 
software, as described in the ‘Methods’ sec-
tion. This number was taken as an indicator of 
the broadness of the natural antibody reper-
toire. This measure was evaluated for IgM and 
IgG from both immunized and non-immun-
ized rats (Figure 2). The natural antibodies 
from the sera of immunized rats recognized a 
greater number of antigens from every organ 
extract, compared to the antibodies from non- 
immunized rats. The magnitudes of these dif-
ferences were moderately isotype dependent. 
The differences in the number of antigens rec-
ognized by natural antibodies from immun-
ized and non-immunized rats were larger with 
IgM antibodies compared to IgG. 
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Figure 1: Binding of natural anti-rat brain IgM in the serum of immunized and non-immunized rats 
as evaluated by immunoblotting. Rat brain extracts were separated by SDS PAGE and probed by 
immunoblotting as described in the ‘Methods’ section. The analysis was limited to 15 animals (n = 8 
immunized; lanes I1 through I8, and n = 7 non-immunized; lanes N1 through N7) due to size con-
straints of the gel. A control strip with no serum is labelled “C”, and indicates the reactivity of the 
anti-IgM conjugate with muscle-derived antigens.  
Figure 2: The natural IgM (top diagram) 
and IgG (bottom diagram) repertoire in im-
munized and non-immunized rats meas-
ured as the mean number of bands pro-
duced on immunoblot  b 
a 
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Natural IgM from immunized rats, on av-
erage, recognized significantly more antigens 
than the natural IgM from non-immunized 
rats, regardless of which organ the antigens 
were from (Figure 2). Natural IgM from im-
munized rats recognized an average of 28 % 
more antigens per organ than did IgM from 
non-immunized rats. The greatest immuniza-
tion-dependent difference in IgM recognition 
was seen with prostate antigens, where the 
IgM from immunized rats recognized an aver-
age of 40 % more antigens. In contrast, the 
smallest difference in IgM recognition be-
tween the two groups was seen with brain an-
tigens, where the natural IgM from immun-
ized rats recognized on average 16 % more 
brain antigens than natural IgM from non-im-
munized rats. 
Natural IgG from the sera of immunized 
rats recognized an average of 14 % more anti-
gens per organ than the natural IgG from the 
sera of non-immunized rats. Subsequently, 
the range of immunization-associated differ-
ence in IgG repertoire was also smaller than 
that of IgM. The IgG from immunized rats 
recognized 18 % more liver antigens than the 
IgG from non-immunized rats, and this was 
the largest difference observed. Meanwhile, 
the immunization-associated difference in the 
average number of lung antigens recognized 
by IgG was less than 1 % and not statistically 
significant. Furthermore, the immunization- 
associated differences in the number of anti-
gens recognized by IgG were only statistically 
significant with respect to antigens from the 
brain and the liver. 
 
Average size of bands formed by natural  
antibody recognition of antigens in non- 
immunized and immunized rats 
The average band size was quantified us-
ing Bio-Rad quantity one software as de-
scribed in the ‘Methods’ section. It was then 
normalized to the average band size produced 
by the sera of non-immunized rats. This aver-
age band size was calculated for IgM and IgG 
binding in all organ extracts. Whilst band 
length is included, pixel intensity is the pri-
mary variable contributing to band size. The 
pixel intensity demonstrates how much anti-
body is bound to the antigen in that specific 
band. Therefore, average band size can be 
taken as the strength with which the antibod-
ies bind to antigens. In this case, it represents 
the average strength of natural antibody bind-
ing to antigens extracted from particular or-
gans. 
Taking the mean of the average band size 
seen with all organ extracts, the mean average 
band size produced by IgM recognition of an-
tigens was 19 % greater with the sera of im-
munized rats compared to non-immunized 
rats (Figure 3). The average band size pro-
duced by IgM from immunized rats was equal 
to or greater than the average band size pro-
duced by IgM from non-immunized rats, re-
gardless of the organ from which the antigens 
were extracted. The largest immunization-as-
sociated differences in average band size were 
seen with brain and liver antigens. With brain 
antigens, the average band size seen with IgM 
from immunized rats was 31 % greater than 
the average band size seen with IgM from 
non-immunized rats. Meanwhile with liver 
antigens, the immunization-associated differ-
ence in average band size was 44 %. No other 
organ extracts displayed statistically signifi-
cant immunization-associated differences in 
average IgM band size.  
Meanwhile, the average band size pro-
duced by natural IgG binding in each organ 
extract was on average 18 % greater with the 
natural IgG from immunized rats as opposed 
to non-immunized rats (Figure 3). However, 
no organ extracts displayed a statistically sig-
nificant difference between the average band 
size produced by the IgG from immunized 
and non-immunized rats. The maximum im-
munization-associated difference in average 
IgG band size was seen with prostate anti-
gens. In this case the IgG from immunized rats 
produced bands that were on average 40 % 
larger than the bands produced by the IgG 
from non-immunized rats. Meanwhile when 
examining brain and kidney antigens, the av-
erage band sizes produced by natural IgM 
from immunized rats were marginally smaller 
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than those produced by natural IgM from non-
immunized rats (Figure 3). 
 
 
Figure 3: The average band size produced by 
the natural IgM (a) and IgG (b) from immunized 
and non-immunized rats binding to antigens 
from different organs 
 
 
Total binding resulting from self-antigen 
recognition by natural antibodies from  
immunized and non-immunized rats 
The total binding for each lane was calcu-
lated as the sum of all band sizes. The mean 
total binding for each group was assessed for 
IgM and IgG natural antibodies and normal-
ized to the mean of the non-immunized group. 
The quantification of total binding reflects 
both the range of the natural antibody reper-
toire (number of bands) and the intensity of 
natural antibody binding (average band size). 
That is, the total binding can be approximated 
as by multiplying the number of bands by the 
average band size. Thus, an increase in either 
antibody repertoire or antibody binding 
strength can increase total binding. 
Compared to natural IgM from non-im-
munized rats, the total binding produced by 
natural IgM from immunized rats was signifi-
cantly greater with all organ extracts except 
the spleen (Figure 4). The average of the im-
munization-associated differences in total 
IgM binding observed in all organ extracts 
was 52 %. In the liver, the natural IgM from 
immunized rats exhibited a mean total binding 
that was 71 % greater than that of IgM from 
non-immunized rats.  
 
 
 
Figure 4: The mean total binding produced by 
the natural IgM (a) and IgG (b) from immunized 
and non-immunized rats binding to antigens 
from different organs 
 
 
It was noted above that total binding re-
flects the number of bands and the average 
band size. With antigens from the kidney, 
prostate and spleen, the relative immuniza-
tion-associated changes in the mean number 
of bands recognized by natural IgM binding 
were larger than the relative differences in the 
average band size. Thus, the immunization- 
associated differences in total binding seen 
with self-antigens from these organs were 
more dependent on the expansion of the natu-
ral IgM repertoire as opposed to alterations in 
antibody binding intensity. In contrast, with 
liver and brain antigens it appears that the im-
munization-associated difference in total IgM 
binding was due in greater part to differences 
in the average band size and thus the intensity 
of antibody binding, although this finding was 
not statistically significant. 
The immunization-associated differences 
in total binding of natural IgG to organ ex-
tracts were not as notable as the differences 
a 
b 
a 
b 
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associated with IgM binding (Figure 4). The 
mean total binding of natural IgG to antigens 
from any organ extract was on average 38 % 
greater with IgG from immunized rats com-
pared to IgG from non-immunized rats. With 
respect to antigens extracted from the liver, 
immunization was associated with an average 
of 57 % greater total IgG binding. This was 
the only statistically significant result ob-
served with total IgG binding. Natural IgG 
recognition of prostatic and splenic antigens 
produced similar magnitude immunization-
associated differences in total binding, but 
these were not statistically significant. 
 
DISCUSSION 
This study examined how a series of 6 im-
munizations over 14 days with a variety of an-
tigens affected the natural IgM and IgG anti-
body repertoires of Sprague Dawley rats. On 
average, the natural antibodies from the sera 
of immunized rats produced a greater number 
of bands, larger average band sizes and 
greater total binding compared to natural anti-
bodies from the sera of non-immunized rats. 
This indicates that in laboratory rats, immun-
ization is associated with a larger natural anti-
body repertoire and stronger antibody bind-
ing, both of which contribute to greater total 
natural antibody binding. 
Larger immunization-associated differ-
ences in natural antibody binding were seen 
with IgM antibodies compared to IgG anti-
bodies. This fits with the current understand-
ing of immunoglobulin class switching, where 
the acute phase of primary antigen exposure is 
characterized by a large IgM response. The 
short time scale of this experiment (28 days) 
may explain the isotype-dependent difference 
since the study was likely terminated before 
the completion of B-cell class switching. It 
might be expected that IgM levels would sub-
side during the isotype switching process, co-
inciding with an increase IgG levels. 
Whilst not as large, immunization-associ-
ated differences in IgG binding were ob-
served. These changes may be a result of early 
isotype switching. Alternatively, IgG may 
have been expressed by B-cells previously 
primed to environmental exposure to antigens 
that cross react with the immunization anti-
gens. The immunization-associated differ-
ences in IgG binding may also be due to T-
cell-independent stimulation. DNP-Ficoll is 
the prototypical antigen for eliciting Type-2 
thymus independent B-cell responses. In vitro 
and in vivo evidence has shown that DNP-Fi-
coll induces IgM and IgG responses. 
The time scale of this experiment may also 
explain disparities in the magnitude of im-
munization-associated differences in the num-
ber of antigens recognized, compared to the 
differences in the average band size. Looking 
specifically at IgM, immunization was associ-
ated with a 28 % difference in the number of 
antigens recognized per organ extract, yet 
only a 19 % difference in the average band 
size per organ extract. Furthermore, the IgM 
from immunized rats recognized significantly 
more antigens in all organ extracts compared 
to IgM from non-immunized rats; whilst the 
immunization-associated difference in the av-
erage band size was only significant with an-
tigens from 2 organ extracts. These observa-
tions suggest that in this experiment, immun-
ization influenced the diversity of the natural 
antibody repertoire to a greater extent than it 
influenced increases in antibody binding to 
specific antigens. It is likely that the acute im-
mune exposure used in this model led to pol-
yclonal B-cell proliferation and an increase in 
the number of different antibodies produced. 
However, the acute nature of the exposure 
may not have allowed sufficient time for B-
cell selection, somatic hyper mutation and the 
resulting affinity maturation that would have 
increased the strength of antibody binding. On 
the other hand, any affinity maturation that 
did occur may have been directed toward the 
antigens used for immunization without di-
rectly affecting the degree of binding toward 
unrelated targets. Future studies aimed at 
evaluating the effect of long term im-
munostimulation on the diversity of the natu-
ral IgG repertoire and on the binding strength 
of natural IgM and IgG antibodies may help 
further elucidate the processes involved. 
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The antigens in the immunization protocol 
were selected to ensure a robust and diverse 
humoral response. Peanut extract was used to 
provoke an IgE response whilst Imject Alum 
was added as an adjuvant to enhance the re-
sponse. DNP-ficol and FITC-KLH were used 
to induce T-dependent and -independent B-
cell responses. DNP-ficoll typifies Type-2 
thymus-independent antigens in that it is a lin-
ear molecule with a repeating antigenic 
epitope (Mond et al., 1995a, b). This structure 
is similar to other T-independent antigens 
such as the capsular polysaccharides of the 
pathogenic bacteria Neisseria meningitides, 
Streptococcus pneumoniae and Haemophilus 
influenza (Mond et al., 1995a, b). Keyhole 
limpet haemocyanin (KLH) is a copper con-
taining, oxygen transporting molecule derived 
from molluscs (Swaminathan et al., 2014). It 
is a highly immunogenic T-dependent antigen 
used clinically for testing T-cell dependent 
immunity. KLH is commonly used for this 
purpose because adult populations have al-
ready been exposed to other readily available 
T-dependent antigens through immunization 
(Swaminathan et al., 2014). These antigens 
include tetanus toxoid, hepatitis B surface an-
tigen and inactivated influenza. Interestingly, 
tetanus toxoid is also used as a protein conju-
gate in juvenile Haemophilus influenzae vac-
cines. 
The findings of this experiment have sev-
eral implications for future research and po-
tentially for clinical practice. The results indi-
cate that it is possible to manipulate the natu-
ral antibody repertoire of laboratory rats by 
selective immunization. This can be accom-
plished relatively quickly (14 days) and with-
out exposing the rats to any pathogens or live 
organisms. Whilst the immunization protocol 
did contain highly immunogenic compounds 
and an adjuvant, it nonetheless successfully 
influenced the natural antibody repertoire 
without the need for infection or exposure to 
potentially infectious organisms. Therefore, it 
may be possible to utilize immunization to 
manipulate the natural antibody repertoire in 
humans for the purpose of preventing or even 
treating disease. 
As previously discussed, natural antibod-
ies are important in innate immune defence as 
well as in cell surveillance and subsequently, 
cancer prevention. Indeed, non-specific ef-
fects of vaccination have been characterized 
in both animals and humans. These effects 
seem to have both positive and negative out-
comes depending on such factors as gender 
and the specific nature of the vaccine sched-
ule. Most studies have examined associations 
between immunization schedules and rates of 
illness across populations of children in low-
income countries. For example, a randomized 
trial in children recruited through the Bandim 
Health Project suggested that, based on mor-
tality rates by age 3, there may be a beneficial 
nonspecific effect of a two dose vaccination 
for measles at 4.5 months and 9 months, as 
opposed to the current approach of vaccinat-
ing against measles once at 9 months only 
(Aaby et al., 2010). The DTP vaccination has 
an ambiguous history of oscillating between 
positive and negative associations, perhaps 
largely due to differences in methodology. 
Amongst the limited number of cohort studies 
that have been conducted, there have been 
mixed findings. Two landmark cohort studies 
found that DTP may diminish childhood mor-
tality, but each assumed children were unvac-
cinated if no history was available, and one 
gave BCG and DPT together, potentially al-
tering outcomes (Chan et al., 2007; Fine et al., 
2009; Shann, 2010; Vaugelade et al., 2004). 
In contrast, a study in Guinea-Bissau com-
pared vaccine schedule and gender differ-
ences among 626 pairs of male-female twins 
through mortality ratio measurements. Find-
ings showed significant differences in mortal-
ity between those sets of twins that received 
BCG as their last vaccine versus DTP as their 
last vaccine, with mortality of the former 
nearly 29 times higher than the latter. It was 
also found that girls had a lower mortality 
rate, compared to boys, when measles or BCG 
was the last vaccine given, but a higher mor-
tality rate when DTP was the last vaccine 
given (Aaby et al., 2004; Shann, 2010). 
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The above examples are only fraction of 
the research demonstrating heterologous ef-
fects of immunization on individuals from 
low-income countries (Benn et al., 2013; Fine 
et al., 2009; Shann, 2010). However, there is 
a clear need for further research on the non-
specific effects of vaccination in higher in-
come and post-industrial areas, which lack a 
majority of the diseases that are widespread in 
lower income countries. Among the limited 
vaccine research in higher income countries is 
a cohort study of Danish children, which 
found that receiving the live MMR vaccine as 
the last immunization on the vaccination 
schedule, compared with the inactive DTap-
IPV-Hib, is associated with lower rates of 
hospital admissions for miscellaneous infec-
tions (Sorup et al., 2014). 
Despite the clear need for further research, 
conducting vaccine research on human sub-
jects in higher income settings may face ethi-
cal and perhaps logistical hurdles. Alterna-
tively, experiments using animal models offer 
a very feasible approach toward modelling the 
nonspecific effects of vaccines in humans liv-
ing in high-income environments. Several an-
imal studies have been conducted to examine 
immunology using wild caught and laboratory 
rats as models for humans living in pre-indus-
trial countries and post-industrial countries, 
respectively (Devalapalli et al., 2006; Lesher 
et al., 2006; Trama et al., 2012). Wild caught 
rats have significantly more natural antibodies 
than their laboratory counterparts (Trama et 
al., 2012). Just as natural antibodies are pro-
duced to a greater extent in a natural or wild 
environment compared to a laboratory envi-
ronment, it seems likely that humans in natu-
ral or pre-industrial conditions produce more 
natural antibodies than do Westernized hu-
mans. 
It seems highly likely that Western society 
provides an environment that leads to an un-
healthy understimulation of the immune sys-
tem (Rook, 2007, 2009). Thus it stands to rea-
son that immune stimulation via immuniza-
tion may provide beneficial nonspecific ef-
fects for high-income countries that it does not 
provide for low-income countries. An artifi-
cial stimulation of the natural antibody reper-
toire, for example, may be more important in 
Western culture than in a developing culture. 
Given that these natural antibodies are im-
portant for surveillance of diseases such as 
cancer, artificial stimulation of an underde-
veloped repertoire that might exist in an envi-
ronment having few natural pathogens seems 
warranted.  
In the future, the Western world will likely 
turn to artificial stimulation of immune func-
tion for health. Vaccination is only one form 
of such stimulation. Indeed, “helminthic ther-
apy” is already being used by many (Cheng et 
al., 2015; Liu et al., 2017) in a Western world 
in which humans are largely devoid of hel-
minths, and it is proposed that exposure to 
helminths may be necessary for normal im-
mune function (Parker et al., 2012, 2013). 
Testing the effects of artificial immune stimu-
lation requires further research, particularly in 
order to elucidate how various forms of artifi-
cial immunostimulation might differentially 
influence immune function and health. 
As Western society continues to make 
progress toward the eradication of infectious 
diseases, the possibility exists that immuniza-
tion will transition from a tool to prevent in-
fectious disease into a means of promoting 
healthy immune function and development. 
This study suggests that immunization may in 
fact be helpful in order to develop a natural 
antibody repertoire that is necessary for effi-
cient surveillance of cancer, and that this 
function of immunization may be most critical 
in a hypothetical environment of the future 
which lacks infectious disease.  
 
REFERENCES 
Aaby P, Jensen H, Rodrigues A, Garly ML, Benn CS, 
Lisse IM, et al. Divergent female-male mortality ratios 
associated with different routine vaccinations among 
female-male twin pairs. Int J Epidemiol. 2004;33:367-
73. 
Aaby P, Martins CL, Garly ML, Bale C, Andersen A, 
Rodrigues A, et al. Non-specific effects of standard 
measles vaccine at 4.5 and 9 months of age on child-
hood mortality: randomised controlled trial. BMJ. 
2010;341:c6495. 
EXCLI Journal 2017;16:1018-1030 – ISSN 1611-2156 
Received: May 26, 2017, accepted: June 20, 2017, published: July 10, 2017 
 
 
1029 
Ailus K, Palosuo T. IgM class autoantibodies in human 
cord serum. J Reprod. Immunol. 1995;29:61-7. 
Benn CS, Netea MG, Selin LK,Aaby P. A small jab - a 
big effect: nonspecific immunomodulation by vac-
cines. Trends Immunol. 2013;34:431-9. 
Casali P, Schettino EW. Structure and function of nat-
ural antibodies. Curr Topics Microbiol Immunol. 
1996;210:167-79. 
Chan GJ, Moulton LH, Becker S, Munoz A,Black RE. 
Non-specific effects of diphtheria tetanus pertussis 
vaccination on child mortality in Cebu, The Philip-
pines. Int J Epidemiol. 2007;36:1022-9. 
Cheng AM, Jaint D, Thomas S, Wilson J, Parker W. 
Overcoming evolutionary mismatch by self-treatment 
with helminths: current practices and experience. J 
Evol Med. 2015;3:235910. 
Devalapalli AP, Lesher A, Shieh K, Solow JS, Everett 
ML, Edala AS, et al. Increased levels of IgE and auto-
reactive, polyreactive IgG in wild rodents: implications 
for the hygiene hypothesis. Scand J Immunol. 2006;64: 
125-36. 
Fine PE, Williams TN, Aaby P, Kallander K, Moulton 
LH, Flanagan KL, et al. Epidemiological studies of the 
'non-specific effects' of vaccines: I. Data collection in 
observational studies. Trop Med Int Health. 2009;14: 
969-76. 
Grönwall C, Vas J, Silverman GJ. Protective roles of 
natural IgM antibodies. Front Immunol. 2012;3:66. 
Guilbert B, Dighiero G, Avrameas S. Naturally occur-
ring antibodies against nine common antigens in human 
sera. J Immunol. 1982;128:2779-86. 
Lacroix-Desmazes S, Kaveri SV, Mouthon L, Ayouba 
A, Malanchere E, Coutinho A, et al. Self-reactive anti-
bodies (natural autoantibodies) in healthy individuals. J 
Immunol Meth. 1998;216:117-37.  
Lesher A, Li B, Whitt P, Newton N, Devalapalli AP, 
Shieh K, et al. Increased IL-4 production and attenu-
ated proliferative and proinflammatory responses of 
splenocytes from wild-caught rats (Rattus Norvegicus). 
Immunol Cell Biol. 2006;84:374-82. 
Liu J, Morey RA, Wilson JK, Parker W. Practices and 
outcomes of self-treatment with helminths based on 
physicians' observations. J Helminthol. 2017;91:267-
77. 
Logtenberg T. Properties of polyreactive natural anti-
bodies to self and foreign antigens. J Clin Immunol. 
1990;10:137-40. 
Lydyard PM, Quartey-Papafio R, Broker B, Mackenzie 
L, Jouquan J, Blaschek MA, et al. The antibody reper-
toire of early human B cells. I. High frequency of auto-
reactivity and polyreactivity. Scand J Immunol. 1990; 
31:33-43. 
Mond JJ, Lees A,Snapper CM. T cell-independent an-
tigens type 2. Annu Rev Immunol. 1995a;13:655-92. 
Mond JJ, Vos Q, Lees A, Snapper CM. T cell inde-
pendent antigens. Curr Opin Immunol. 1995b;7:349-
54. 
Parker W, Yu PB, Holzknecht ZE, Lundberg K, Buck-
ley RH, Platt JL. Specificity and function of "natural" 
antibodies in immunodeficient subjects: clues to B cell 
lineage and development. J Clin Immunol. 1997;17: 
311-21. 
Parker W, Perkins SE, Harker M, Muehlenbein MP. A 
prescription for clinical immunology: the pills are 
available and ready for testing. Curr Med Res Opin. 
2012;28:1193-202. 
Parker W, Ollerton J. Evolutionary biology and anthro-
pology suggest biome reconstitution as a necessary ap-
proach toward dealing with immune disorders. Evol 
Med Public Health. 2013;2013:89–103. 
Pi C, Allott EH, Ren D, Poulton S, Lee SY, Perkins S, 
et al. Increased biodiversity in the environment im-
proves the humoral response of rats. PLoS One. 
2015;10:e0120255. 
Quan CP, Berneman A, Pires R, Avrameas S, Bouvet 
JP. Natural polyreactive secretory immunoglobulin A 
autoantibodies as a possible barrier to infection in hu-
mans. Infect Immun. 1997;65:3997-4004. 
Rook GAW. The hygiene hypothesis and the increasing 
prevalence of chronic inflammatory disorders. Trans R 
Soc Trop Med Hyg. 2007;101:1072-4. 
Rook GAW. Review series on helminths, immune 
modulation and the hygiene hypothesis: the broader im-
plications of the hygiene hypothesis. Immunology. 
2009;126:3-11. 
Schwartz-Albiez R, Monteiro RC, Rodriguez M, 
Binder CJ, Shoenfeld Y. Natural antibodies, intrave-
nous immunoglobulin and their role in autoimmunity, 
cancer and inflammation. Clin Exp Immunol. 2009;158 
(Suppl 1):43-50. 
Shann F. The non-specific effects of vaccines. Arch Dis 
Child. 2010;95:662-7.  
Sorup S, Benn CS, Poulsen A, Krause TG, Aaby P, 
Ravn H. Live vaccine against measles, mumps, and ru-
bella and the risk of hospital admissions for nontar-
geted infections. JAMA. 2014;311:826-35. 
EXCLI Journal 2017;16:1018-1030 – ISSN 1611-2156 
Received: May 26, 2017, accepted: June 20, 2017, published: July 10, 2017 
 
 
1030 
Spalter SH, Kaveri SV, Bonnin E, Mani JC, Cartron JP, 
Kazatchkine MD. Normal human serum contains natu-
ral antibodies reactive with autologous ABO blood 
group antigens. Blood. 1999;93:4418-24. 
Stahl D, Lacroix-Desmazes S, Mouthon L, Kaveri SV, 
Kazatchkine MD. Analysis of human self-reactive an-
tibody repertoires by quantitative immunoblotting. J 
Immunol Meth. 2000;240:1-14. 
Swaminathan A, Lucas RM, Dear K, McMichael AJ. 
Keyhole limpet haemocyanin - a model antigen for hu-
man immunotoxicological studies. Br J Clin Pharma-
col. 2014;78:1135-42. 
Trama AM, Holzknecht ZE, Thomas AD, Su KY, Lee 
SM, Foltz EE, et al. Lymphocyte phenotypes in wild-
caught rats suggest potential mechanisms underlying 
increased immune sensitivity in post-industrial envi-
ronments. Cell Mol Immunol. 2012;9:163-74. 
Umar A. Cancer immunoprevention: a new approach to 
intercept cancer early. Cancer Prev Res (Phila). 2014;7: 
1067-71. 
Vassilev TL,Veleva KV. Natural polyreactive IgA and 
IgM autoantibodies in human colostrum. Scand J Im-
munol. 1996;44:535-9. 
Vaugelade J, Pinchinat S, Guiella G, Elguero E, Simon-
don F. Non-specific effects of vaccination on child sur-
vival: prospective cohort study in Burkina Faso. BMJ. 
2004;329(7478):1309. 
Vollmers HP, Brandlein S. Natural antibodies and can-
cer. Nature Biotechnol. 2009;25:294-8. 
 
